NEW YORK (GenomeWeb News) - Sequenom CEO Harry Stylli bought 13,313 shares of the company's stock at an average price of $1.86 per share for total proceeds of $24,964 on Aug. 11, according to documents filed with the Securities and Exchange Commission.
Since Aug. 7, he purchased 53,700 shares for total proceeds of $96,565. He currently owns 54,700 shares of Sequenom stock.
Shares in Sequenom were up 5 percent, or $.10, to $1.95 in mid-afternoon trading today. The shares are up 15 percent since Aug. 7, when Stylli began buying the stock.